ARCHIVES

Intense Therapies Better Than Lower Dose For AML

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP

March 11, 1988

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

Home-Based Program Helps Older Cancer Survivors

May 29, 2009

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004